PharmaVitae explores Ionis Pharmaceuticals’ prescription pharmaceutical performance and outlook over 2019–29.
Snapshot Overview – Ionis’s prescription pharmaceutical business will see strong growth over the forecast period. Key themes –  Spinraza royalties will comprise the majority of Ionis’s revenues for the foreseeable future  Pharmaceutical business growth driven by launches of Tegsedi and Waylivra.
Model updates (6 May 2020)
No changes to forecast.
Model updates (26 February 2020)
Waylivra forecast adjusted lower due to slower-than-anticipated launch.
Model updates (11 November 2019)
Waylivra US launch delayed until 2022 Tegsedi forecast adjusted lower due to slower-than-anticipated launch.
Model updates (12 July 2019)
Tegsedi sales adjusted lower due to pace of sales ramp Waylivra launch delayed in the five major EU markets until Q3 2019, and in RoW until Q1 2020.
Our reports have been used by over 10K customers, including:
Anti-obesity Prescription Drugs Market Research Report by Drug Class (Bupropion and Naltrexone, Liraglutide, Lorcaserin, Orlistat, and Phentermine and Topiramate), by Age Group (Adult and Pediatric), by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Anti-obesity Prescription...
112 pages •
By Euromonitor International
• Nov 2020
Consumer health in Slovakia is expected to show considerable resilience in response to the COVID-19 pandemic. Despite troubling economic circumstances, many consumers saw consumer health products as indispensable and continued to buy them despite decreasing incomes. Initial stockpiling in March did cause some product shortages, particularly...
PharmaVitae explores Biogen’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Biogen’s prescription pharmaceutical business will see stable performance over the medium term. Key themes –  Biogen’s flagship MS portfolio – Tecfidera, Avonex, Plegridy, and Tysabri – remains...
122 pages •
By Euromonitor International
• Oct 2020
The outbreak of Coronavirus (COVID-19) and the subsequent lockdown have had a strong effect on consumer health in Belgium. Thus, there have been significant switches from category to category, as well as one distribution channel to another due to strong restrictions on retailing. Consumer Health in Belgium report offers a comprehensive...
The North America Over the Counter (OTC) Drugs Market is anticipated to grow with a CAGR of 2.7%, during the forecast period. The OTC drugs market is innovation-driven and relies on the advent of innovative drugs for different disease complexities and vary in their degree of intensity, and efficacy. The product innovations in OTC drugs...
227 pages •
By Asia Market Information & Development Company
• Jan 2021
China’s demand for Sleep Disorder Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export,...
266 pages •
By The Business Research Company
• Dec 2020
Filgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth provides the strategists, marketers and senior management with the critical information they need to assess the global Filgrastim Biosimilars market. Description: Where is the largest and fastest growing market...
The Europe patient controlled injectors market is expected to reach US$ 2,051.31 million by 2027 from US$ 835.44 million in 2019; it is expected to grow at a CAGR of 12.0% from 2020 to 2027. The increasing prevalence of chronic diseases and limitations on conventional drug delivery system boost the growth of the market.However, the preference...
The global osteoarthritis therapeutics market is projected to reach USD 11.0 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 8.7% from 2020 to 2025. The growth of this market is driven significant adoption of pain medications, increasing prevalence of osteoarthritis, growing population susceptible to osteoarthritis, and rising number...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.